UAB "Pharmasanta group" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
111,026 |
23,522 |
368,844 |
-368,844 |
-78,145 |
22.38 |
-332.21 |
-1,447,111 |
12,820,340 |
11,022,262 |
350,531 |
2023 |
---|
75,150 |
19,025 |
1,440,679 |
1,440,679 |
364,729 |
14.23 |
1,917.07 |
-6,432 |
11,264,332 |
10,918,240 |
339,603 |
2024 |
---|
57,600 |
25,374 |
1,754,546 |
1,754,546 |
772,928 |
30.60 |
3,046.09 |
1,748,115 |
11,709,581 |
13,396,779 |
60,428 |
Register and
explore Okredo dataRegister and
explore Okredo data2024
Turnover (€)
57,600 €-23 % *
Sales per employee (€)
25,374 €33 % *
Profit before tax (€)
1,754,546 €22 % *
Net Profit (€)
1,754,546 €22 % *
Profit per employee (€)
772,928 €112 % *
Total profitability (%)
30.60 %115.04 % *
Net profitability (%)
3,046.09 %58.89 % *
Equity (€)
1,748,115 €27,278 % *
Amounts Payable And Liabilities (€)
11,709,581 €4 % *
Non-current Assets (€)
13,396,779 €23 % *
CurrentAssets (€)
60,428 €-82 % *